Azzad Asset Management Inc /Adv Biogen Inc. Transaction History

Azzad Asset Management Inc /Adv

$891 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Apr 01, 2024	SELL	$252.44 - $306.72 $1.37 Million - $1.67 Million	-5,438 Closed	0 $0
Q3 2022 Apr 01, 2024	SELL	$194.69 - $268.46 $1,752 - $2,416	-9 Reduced 0.17%	5,438 $1.45 Billion
Q2 2022 Apr 01, 2024	BUY	$187.54 - $223.02 $1.02 Million - $1.21 Million	5,447 New	5,447 $1.44 Billion
Q2 2021 Apr 01, 2024	SELL	$259.0 - $414.71 $1.66 Million - $2.66 Million	-6,411 Closed	0 $0
Q1 2021 Apr 01, 2024	BUY	$242.95 - $284.63 $52,477 - $61,480	216 Added 3.49%	6,411 $1.79 Billion
Q4 2020 Apr 01, 2024	SELL	$236.26 - $355.63 $9,450 - $14,225	-40 Reduced 0.64%	6,195 $1.52 Billion
Q3 2020 Apr 01, 2024	BUY	$264.77 - $305.71 $263,975 - $304,792	997 Added 19.03%	6,235 $1.77 Billion
Q2 2020 Apr 01, 2024	BUY	$258.66 - $342.55 $621,301 - $822,805	2,402 Added 84.7%	5,238 $1.4 Billion
Q1 2020 Apr 01, 2024	SELL	$268.85 - $341.04 $1.39 Million - $1.77 Million	-5,179 Reduced 64.62%	2,836 $897 Million
Q4 2019 Apr 01, 2024	BUY	$220.06 - $304.07 $9,242 - $12,770	42 Added 0.53%	8,015 $2.23 Billion
Q3 2019 Apr 01, 2024	BUY	$217.44 - $243.88 $1.14 Million - $1.28 Million	5,258 Added 193.66%	7,973 $2.04 Billion
Q2 2019 Apr 01, 2024	BUY	$219.29 - $241.72 $244,946 - $270,001	1,117 Added 69.9%	2,715 $635 Million
Q1 2019 Apr 01, 2024	SELL	$216.71 - $338.96 $4,767 - $7,457	-22 Reduced 1.36%	1,598 $378 Million
Q4 2018 Apr 01, 2024	SELL	$278.5 - $352.75 $32,863 - $41,624	-118 Reduced 6.79%	1,620 $488 Million
Q3 2018 Apr 01, 2024	SELL	$293.51 - $383.83 $4,989 - $6,525	-17 Reduced 0.97%	1,738 $614 Million
Q2 2018 Apr 01, 2024	BUY	$257.52 - $306.91 $451,947 - $538,627	1,755 New	1,755 $509 Million
Q1 2018 Apr 03, 2024	BUY	$260.13 - $367.91 $12,226 - $17,291	47 Added 2.81%	1,720 $471 Million
Q4 2017 Apr 03, 2024	BUY	$307.64 - $344.58 $24,303 - $27,221	79 Added 4.96%	1,673 $533 Million
Q3 2017 Apr 03, 2024	BUY	$281.15 - $329.69 $26,428 - $30,990	94 Added 6.27%	1,594 $499 Million
Q2 2017 Apr 03, 2024	BUY	N/A	132 Added 9.65%	1,500 $407 Million
Q1 2017 Apr 03, 2024	BUY	N/A	127 Added 10.23%	1,368 $374 Million
Q4 2016 Apr 03, 2024	BUY	N/A	44 Added 3.68%	1,241 $352 Million
Q3 2016 Apr 03, 2024	SELL	N/A	-19 Reduced 1.56%	1,197 $375 Million
Q2 2016 Apr 03, 2024	BUY	N/A	420 Added 52.76%	1,216 $294 Million
Q1 2016 Apr 03, 2024	BUY	N/A	116 Added 17.06%	796 $207 Million
Q4 2015 Apr 03, 2024	BUY	N/A	680	680 $208 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.44 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.39 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.13 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.08 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$752 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.

Account